Cargando…

Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma

BACKGROUND: In reproductive-aged women, the incidence of atypical endometrial hyperplasia (AEH) or endometrioid endometrial carcinoma (EEC) is rising globally. The study aimed to investigate the effectiveness of hysteroscopic curettage followed by megestrol acetate (MA) plus metformin as conservativ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jing, Chu-Yu, Li, Sheng-Nan, Shan, Bo-Er, Zhang, Wei, Tian, Wen-Juan, Ren, Yu-Lan, Wang, Hua-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Current situation and prospect of gynecological tumors and fertility preservation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297462/ https://www.ncbi.nlm.nih.gov/pubmed/35875417 http://dx.doi.org/10.1177/11795549221110522

Ejemplares similares

Prognostic Values From Integrated Analysis of the Nomogram Based on RNA-Binding Proteins and Clinical Factors in Endometrial Cancer
por: Yuan, Shuang, et al.
Publicado: (2022)

Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia
por: Shan, Weiwei, et al.
Publicado: (2014)

Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer
por: Kim, S. Samuel, et al.
Publicado: (2012)

Fertility in young patients following treatment for Hodgkin’s lymphoma: a single center survey
por: Boltežar, Lučka, et al.
Publicado: (2015)

The role of menstrual cycle phase and AMH levels in breast cancer patients whose ovarian tissue was cryopreserved for oncofertility treatment
por: Takae, Seido, et al.
Publicado: (2014)

Re-implantation of cryopreserved ovarian cortex resulting in restoration of ovarian function, natural conception and successful pregnancy after haematopoietic stem cell transplantation for Wilms tumour
por: Dunlop, C. E., et al.
Publicado: (2016)

Follicular growth after xenotransplantation of cryopreserved/thawed human ovarian tissue in SCID mice: dynamics and molecular aspects
por: Ayuandari, Sarrah, et al.
Publicado: (2016)

Clinically applied procedures for human ovarian tissue cryopreservation result in different levels of efficacy and efficiency
por: Bastings, Lobke, et al.
Publicado: (2016)

Complete protection against cryodamage of cryopreserved whole bovine and human ovaries using DMSO as a cryoprotectant
por: Westphal, Johan R., et al.
Publicado: (2017)

Cryopreservation and transplantation of ovarian tissue: results from one center in the USA
por: Silber, Sherman J., et al.
Publicado: (2018)

Equal opportunity for all? An analysis of race and ethnicity in fertility preservation in New York City
por: Voigt, Paxton E., et al.
Publicado: (2020)

Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer
por: Porcu, Eleonora, et al.
Publicado: (2019)

Influence of graft size, histocompatibility,and cryopreservation on reproductive outcome following ovary transplantation in mice
por: Kolbe, T., et al.
Publicado: (2019)

Counseling young women with early breast cancer on fertility preservation
por: ter Welle-Butalid, M. E. (Elena), et al.
Publicado: (2019)

Oncofertility case report: live birth 10 years after oocyte in vitro maturation and zygote cryopreservation
por: Rodrigues, P., et al.
Publicado: (2020)

Installing oncofertility programs for breast cancer in limited versus optimum resource settings: Empirical data from 39 surveyed centers in Repro-Can-OPEN Study Part I & II
por: Salama, Mahmoud, et al.
Publicado: (2022)

Purging human ovarian cortex of contaminating leukaemic cells by targeting the mitotic catastrophe signalling pathway
por: Eijkenboom, Lotte, et al.
Publicado: (2021)

Challenging cases in oncofertility: insights from a national specialized e-meeting for fertility preservation specialists
por: Khiat, Samuel, et al.
Publicado: (2021)

Installing oncofertility programs for common cancers in optimum resource settings (Repro-Can-OPEN Study Part II): a committee opinion
Publicado: (2021)

Primary ovarian insufficiency secondary to chemotherapy with inotuzumab ozogamicin and other agents
por: Maristany, Sumiko, et al.
Publicado: (2022)

A synopsis of global frontiers in fertility preservation
por: Ataman, L. M., et al.
Publicado: (2022)

Current status and reflections on fertility preservation in China
por: Zhang, Jiakai, et al.
Publicado: (2022)

Pediatric oncofertility care in limited versus optimum resource settings: results from 39 surveyed centers in Repro-Can-OPEN Study Part I & II
por: Salama, M, et al.
Publicado: (2022)

Clinical pregnancy in Turner syndrome following re-implantation of cryopreserved ovarian cortex
por: Dunlop, CE, et al.
Publicado: (2023)

Contraceptive methods and fertility testing in young adult survivors of childhood cancer
por: Cherven, Brooke, et al.
Publicado: (2023)

Long-term effect of chemotherapy after ovarian decortication on the ovarian function in women surviving cancer
por: Ortiz, Ester, et al.
Publicado: (2023)

Preservation of fertility in female and male prepubertal patients diagnosed with cancer
por: Albamonte, María Itatí, et al.
Publicado: (2023)

Effectiveness of Megestrol for the Treatment of Patients with Atypical Endometrial Hyperplasia or Endometrial Endometrioid Adenocarcinoma (Stage IA, Well Differentiated)
por: Akhavan, Setareh, et al.
Publicado: (2021)

Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy
por: Ga, Hiromi, et al.
Publicado: (2023)

Reproduction in life and death: should cancer patients with a poor prognosis be offered fertility preservation interventions?
por: Jones, Georgina L, et al.
Publicado: (2023)

Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia
por: Girbash, Ehab F., et al.
Publicado: (2023)

CD44 expression in curettage and postoperative specimens of endometrial cancer
por: Wojciechowski, Michał, et al.
Publicado: (2014)

Endometrial hyperplasia as a risk factor of endometrial cancer
por: Nees, Lisa K., et al.
Publicado: (2022)

The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas
por: Zhan, Xiangbo, et al.
Publicado: (2019)

Levonorgestrel-releasing intrauterine device plus metformin, or megestrol acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and early endometrial carcinoma: a prospective, randomized, blind-endpoint design trial protocol
por: Zhao, Xin, et al.
Publicado: (2022)

Pregnancy Rates after Hysteroscopic Endometrial Polypectomy versus Endometrial Curettage Polypectomy: A Retrospective Study
por: Nishioka, Mikiko, et al.
Publicado: (2023)

Novel application to evaluate endometrial blood flow using transvaginal superb microvascular imaging: A preliminary study describing physiological changes from ovulation to mid‐luteal phase
por: Mitao, Hiroshi, et al.
Publicado: (2023)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
por: Guan, Jun, et al.
Publicado: (2022)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
por: Kuai, Dan, et al.
Publicado: (2023)

Ovarian and Endometrial Endometrioid Carcinoma Following the Use of a Biologic IL-17 Inhibitor
por: Babcock, Luke, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sogfqhm5mc7uac96q61lngto15